Organic Chromium Form Alleviates the Detrimental Effects of Heat Stress on Nutrient Digestibility and Nutrient Transporters in Laying Hens. Orhan Cemal,Tuzcu Mehmet,Deeh Patrick Brice Defo,Sahin Nurhan,Komorowski James R,Sahin Kazim Biological trace element research In the present study, we investigated the effects of chromium-picolinate (CrPic) and chromium-histidinate (CrHis) on nutrient digestibility and nutrient transporters in laying hens exposed to heat stress (HS). Hens (n = 1800; 16 weeks old) were kept in cages in temperature-controlled rooms at either 22 ± 2 °C for 24 h/day (thermoneutral (TN)) or 34 ± 2 °C for 8 h/day, from 08:00 to 17:00, followed by 22 °C for 16 h (HS) for 12 weeks. Hens reared under both environmental conditions were fed one of three diets: a basal diet and the basal diet supplemented with either 1.600 mg of CrPic (12.43% Cr) or 0.788 mg of CrHis (25.22% Cr) per kg of diet, delivering 200 μg elemental Cr per kg of diet. HS impaired the nutrient digestibility and nutrient transports in laying hens (P < 0.001). However, both Cr sources increased digestibility of dry matter (DM; P < 0.001), organic matter (OM; P < 0.05), crude protein (CP; P < 0.001), and crude fat (CF; P < 0.001). Both Cr sources partially alleviated detrimental effects of HS on fatty acid-binding and transport protein1 (FABP1, FATP1), glucose (SGLT1, GLUT1, GLUT10), protein (PepT1, PepT2), and amino acid transporters (ASCT1, bAT1, CAT1, EAAT1, LAT1) of the ileum (P < 0.0001). The efficacy of Cr as CrHis was more notable than Cr as CrPic, which could be attributed to higher bioavailability. Finally, the detrimental effects of HS on nutrient digestibility and nutrient transporters were alleviated by CrPic and CrHis. These findings may justify the use of CrPic and CrHis in poultry. 10.1007/s12011-018-1485-9

Effects of different sources and levels of dietary chromium supplementation on performance of broiler chicks. Animal science journal = Nihon chikusan Gakkaiho The current experiment was carried out to evaluate the effect of different dietary chromium supplementation sources, chromium oxide (Cr O ), chromium methionine (Cr-Met), or chromium yeast (Cr-yeast), at different levels each (500 or 1,000 ppb) on growth performance, physiological traits, and carcass characteristics of broiler chicks. A total of 490 seven-day-old Arbor Acres chicks were randomly distributed into 7 experimental groups each in 10 replicates of 7 birds each. The groups were control, 500 ppb Cr O , 1,000 ppb Cr O , 500 ppb Cr-Met, 1,000 ppb Cr-Met, 500 ppb Cr-yeast, and 1,000 ppb Cr-yeast. The results showed significant superiority of the organic chromium sources (Cr-Met or Cr-yeast) concerning body weight and weight gain, the group supplemented with 1,000 ppb Cr-yeast consumed the lowest feed (3,185 g) and had the best feed conversion ratio (1.60) compared to the control (1.73). The chromium treatments recorded significantly better protein and lipid profile, antioxidant status, and immunological parameters than the control group. Similarly, dietary chromium supplementation increased carcass yield and decreased intestinal pathogenic bacteria. In conclusion, supplementing broiler diets with organic chromium sources at 1,000 ppb promotes growth performance, physiological traits, and carcass characteristics; such chromium treatments enhanced the antioxidant status and immunity levels of broilers. 10.1111/asj.13448

Systematic Review of the Effects of Chromium(III) on Chickens. White Pandora E,Vincent John B Biological trace element research Chromium supplementation has been proposed to have beneficial effects in farm animals, particularly when under stress. The last two decades, in particular, have seen an emphasis on examining the effects of supplemental chromium on a variety of variables in chicks and chickens. Thus, given the recent approval of a Cr(III) compound for use in chicken feed in the United States and the recent surge in papers on the use of Cr in chicken feed, the need for a systematic review of studies utilizing chickens is extremely urgent and timely. With the exception of studies on cold-stressed laying hens, the results of studies of Cr supplementation of chickens, whether broilers or laying hens, were found to be too inconsistent for any firm conclusions to be drawn other than that Cr supplementation generally leads to accumulation of Cr in tissues. Few potential trends in terms or beneficial or deleterious effects from Cr supplementation were found regardless of strain of chicken, Cr source, Cr dose, duration of supplementation, or variable examined. Hence, in summary, no recommendation for the use of Cr as a supplement for the diet of chickens can be made at this time. 10.1007/s12011-018-1575-8

A meta-analysis of the effect of chromium supplementation on anthropometric indices of subjects with overweight or obesity. Tsang Catherine,Taghizadeh Mohsen,Aghabagheri Elahe,Asemi Zatollah,Jafarnejad Sadegh Clinical obesity The role of chromium as a weight loss agent remains questionable, and although previous meta-analyses findings have reported small reductions in body weight in individuals with overweight/obesity following chromium supplementation, there have been significant limitations with these findings. The objective of this meta-analysis was to evaluate the current evidence for the efficacy of oral chromium supplementation in individuals with overweight/obesity from randomized controlled trials. Studies were identified by a search of electronic databases from inception to November 2018 and combined and stratified analyses were used. Twenty-one trials from 19 studies were identified which met all inclusion criteria which were suitable for statistical pooling, and data from 1316 participants were included. Pooled analysis showed significant reductions in anthropometric indices associated with body composition; for weight loss (weighted mean difference [WMD]: -0.75 kg, 95% confidence interval [CI], -1.04, -0.45, P < 0.001), body mass index (WMD: -0.40, 95% CI, -0.66, -0.13, P = 0.003 and body fat percentage (WMD: -0.68%, 95% CI, -1.32, -0.03, P = 0.04) in individuals with overweight/obesity. No changes were detected in controls. Subgroup analysis showed significant improvements in weight loss and body fat percentage, particularly for study durations ≤12 weeks and doses ≤400 μg/d. Chromium supplementation was associated with some improvements in body composition in subjects with obesity/overweight. The effect size was medium and the clinical relevance of chromium as a weight loss aid remains uncertain. Further investigation from larger and well-designed randomized controlled studies, especially in patients with diabetes, is warranted. 10.1111/cob.12313

Potential roles of chromium on inflammatory biomarkers in diabetes: A Systematic. Moradi Fardin,Maleki Vahid,Saleh-Ghadimi Sevda,Kooshki Fatemeh,Pourghassem Gargari Bahram Clinical and experimental pharmacology & physiology Diabetes, as a low-grade chronic inflammatory disease, causes disruption in proper function of immune and metabolic system. Chromium is an important element required for normal lipid and glucose metabolism. Chromium deficiency is correlated with elevation in cardiometabolic risk, which results from increased inflammation. This systematic review was conducted to discover the potential roles of chromium on inflammatory biomarkers. Eligible studies were all in vitro, animal and human studies published in English-language journals from inception until October 2018. PubMed, Scopus, Embase, ProQuest and Google Scholar databases were searched to fined interventional studies from the effects of chromium on inflammatory biomarkers such as tumour necrosis factor a (TNF-a), C-reactive protein (CRP), interleukins, monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion molecule-1 (ICAM-1) and adipocytokines in hyperglycaemia and diabetes. Out of 647 articles found in the search, only 14 articles were eligible for analysis, three in vitro studies, eight animal studies and three human studies. Twelve of the 14 studies included in this review, chromium significantly decreased inflammatory factors. The findings of this review indicate, based on in vitro and in vivo studies, that chromium might have potential anti-inflammatory properties, but some of the studies did not show anti-inflammatory effects for chromium (two studies). There are only three studies in humans with controversial results. Therefore, more consistent randomized double-blind controlled trials are needed to reach relevant clinical recommendations, as well as to determine the precise mechanism, of chromium on inflammation in diabetes. 10.1111/1440-1681.13144